
25.03.2024
Acino appoints Samir El Nasharty as Chief Operations Officer
We are pleased to announce the appointment of Samir El Nasharty as Chief Operations Officer and member of Acino’s Executive...
We are pleased to announce the appointment of Samir El Nasharty as Chief Operations Officer and member of Acino’s Executive...
M8 Pharmaceuticals, an Acino company (“M8”) and SERB Pharmaceuticals (“SERB”), a global specialty pharmaceutical company, are collaborating to bring an...
We are proud to announce the appointment of Ingrid Eberle as Chief Compliance and Sustainability Officer, effective 1 March 2024....
The agreement focuses on the distribution of orphan drugs developed for patients with conditions such as rheumatoid arthritis, cryopyrin-associated periodic...
For the third consecutive year, Acino South Africa has been awarded with the Top Employer certification. The Top Employer certification is one...
With nearly 300 new employees on board, Acino will enhance its presence in Latin America and strengthen its business through...
Antimicrobial resistance (AMR) is a global health concern that threatens the effectiveness of antibiotics and other antimicrobial medicines. It has the...
In line with Acino’s commitment to improving patients’ lives, we regularly organise health awareness initiatives with our employees, the ambassadors...
Acino, recognizes the significance of cardiovascular health and is dedicated to advancing heart care through innovative solutions and patient education....